par Testori, Alessandro;Suciu, Stefan 
;van Akkooi, Alexander A.C.J.;Cook, Martin;Ghanem, Ghanem Elias ;Karra Gurunath, R.;Keilholz, Ulrich;van Kempen, Leon;Leyvraz, Serge;Mihm, Martin;Newton-Bishop, Julia;Patel, Poulam;Robert, Caroline;Schadendorf, Dirk;de Schaetzen, Gaetan;Spatz, Alan;De Vries, Esther;Eggermont, Alexander A.M.M.
Référence European journal of cancer, 10, 1, page (112-119)
Publication Publié, 2012-03
;van Akkooi, Alexander A.C.J.;Cook, Martin;Ghanem, Ghanem Elias ;Karra Gurunath, R.;Keilholz, Ulrich;van Kempen, Leon;Leyvraz, Serge;Mihm, Martin;Newton-Bishop, Julia;Patel, Poulam;Robert, Caroline;Schadendorf, Dirk;de Schaetzen, Gaetan;Spatz, Alan;De Vries, Esther;Eggermont, Alexander A.M.M.Référence European journal of cancer, 10, 1, page (112-119)
Publication Publié, 2012-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Testori, Alessandro; Suciu, Stefan; van Akkooi, Alexander A.C.J.; Cook, Martin; Ghanem, Ghanem Elias; Karra Gurunath, R.; Keilholz, Ulrich; van Kempen, Leon; Leyvraz, Serge; Mihm, Martin; Newton-Bishop, Julia; Patel, Poulam; Robert, Caroline; Schadendorf, Dirk; de Schaetzen, Gaetan; Spatz, Alan; De Vries, Esther; Eggermont, Alexander A.M.M. |
| Informations sur la publication: | European journal of cancer, 10, 1, page (112-119) |
| Statut de publication: | Publié, 2012-03 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | Clinical research |
| Interferon | |
| Melanoma | |
| Prognostic factors | |
| Temozolomide | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1359-6349 |
| info:doi/10.1016/S1359-6349(12)70020-4 | |
| info:pii/S1359634912700204 | |
| info:scp/84858164036 |
